PTPN22 regulates T cell synapse formation through PSTPIP1-dependent actin remodeling
Science Signaling · 09.06.2026 · 19 (941)
DOI: 10.1126/scisignal.ady6063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, erschienen am 09.06.2026. Verfasst von Megan D Joseph und 6 weiteren Autor:innen. Beteiligte Einrichtung: London Centre for Nanotechnology, University College London, WC1H 0AH London, UK. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, Protein Tyrosine Phosphatase, Non-Receptor Type 22, Immunological Synapses, Actins. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Chan Zuckerberg Initiative, Kennedy Trust for Rheumatology Research, Engineering and Physical Sciences Research Council.
Abstract (Originalsprache)
Protein tyrosine phosphatase nonreceptor type 22 (PTPN22) is a key negative regulator of T cell activation, acting with C-terminal Src kinase (Csk) to suppress early T cell receptor (TCR) signaling and maintain immune tolerance. Given that the autoimmune disease–associated R620W variant alters T cell responses, we investigated the effects of PTPN22 on T cell activation. We identified a role for PTPN22 in modulating cytoskeletal dynamics at the immunological synapse in Jurkat cells through its interaction with proline-serine-threonine phosphatase–interacting protein 1 (PSTPIP1), a cytoskeletal adaptor protein that recruits actin nucleation–promoting factors, including WASp, to the TCR. PTPN22 deficiency or inhibition disrupted Arp2/3-dependent actin remodeling, leading to excessive central F-actin foci, PSTPIP1 mislocalization, and enhanced Ca 2+ signaling, especially under low-affinity stimulation of the TCR. Super-resolution DNA-PAINT analysis revealed that loss of PTPN22 promoted aberrant PSTPIP1-TCR nanoscale colocalization and increased TCR clustering. These findings uncover a PTPN22-PSTPIP1 signaling axis that is critical for regulating cytoskeletal remodeling and receptor organization, providing insights into T cell hyperactivation that may be relevant to autoimmune disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- London Centre for Nanotechnology, University College London, WC1H 0AH London, UK.
- Department of Chemistry, University College London, WC1H 0AJ London, UK.
- Molecular and Cellular Immunology Section, Great Ormond Street Institute of Child Health, University College London, WC1N 1EH London, UK.
- Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford, OX3 7FY Oxford, UK.
- Chinese Academy of Medical Sciences Oxford Institute, Nuffield Department of Medicine, University of Oxford, OX3 7BN Oxford, UK.
- Centre for Inflammation Biology & Cancer Immunology, King's College London, New Hunt's House, SE1 9RT London, UK.
ORCID-Profile: Megan D Joseph, Cecilia Zaza, Olivia P L Dalby, Michael L Dustin, Andrew P Cope, Sabrina Simoncelli
Förderung
- Chan Zuckerberg Initiative
- Kennedy Trust for Rheumatology Research
- Engineering and Physical Sciences Research Council
- Biotechnology and Biological Sciences Research Council
- Royal Society
- Human Frontier Science Program
- Institute of Child Health, University College London
- Versus Arthritis
Zitieren
APA
Joseph, M. D., Zaza, C., Dalby, O. P. L., Kirtsios, E., Dustin, M. L., Cope, A. P., & Simoncelli, S. (2026). PTPN22 regulates T cell synapse formation through PSTPIP1-dependent actin remodeling. Science Signaling, 19(941). https://doi.org/10.1126/scisignal.ady6063
Vancouver
Joseph MD, Zaza C, Dalby OPL, Kirtsios E, Dustin ML, Cope AP, et al. PTPN22 regulates T cell synapse formation through PSTPIP1-dependent actin remodeling. Science Signaling. 2026;19(941). doi:10.1126/scisignal.ady6063
BibTeX
@article{Joseph2026,
author = {Joseph, Megan D and Zaza, Cecilia and Dalby, Olivia P L and Kirtsios, Efstratios and Dustin, Michael L and Cope, Andrew P and Simoncelli, Sabrina},
title = {PTPN22 regulates T cell synapse formation through PSTPIP1-dependent actin remodeling},
journal = {Science Signaling},
year = {2026},
volume = {19},
number = {941},
doi = {10.1126/scisignal.ady6063}
}
EUVIMED